test

Nir Messafi

@Deep Track Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$3.153BTotal holdings69
Assets growth rate-5.9%Assets growth rate (2-Q avg)-4.96%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Deep Track Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Deep Track Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.153B in assets, with a quarterly growth rate of -5.9% and a 2-quarter average growth rate of -4.96%. The portfolio is managed by Nir Messafi, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ARGXArgenx Se
Recent Activity
Decreased -8.75%
6.28%
$197.859M
365,000 shares@ $542.08 avg price
DYNDyne Therapeutics Inc
Recent Activity
Decreased -17.95%
3.74%
$117.889M
3.282M shares@ $35.92 avg price
AXSMAxsome Therapeutics Inc
Recent Activity
Decreased -42.93%
3.02%
$95.012M↑ Call
1.057M shares@ $89.88 avg price
VRNAVerona Pharma Plc
Recent Activity
Decreased -20.49%
2.91%
$91.489M
3.18M shares@ $28.77 avg price
NRIXNurix Therapeutics Inc
Recent Activity
Decreased -3.09%
2.76%
$86.916M
3.868M shares@ $22.48 avg price
VRDNViridian Therapeutics Inc
Recent Activity
Decreased -4.4%
2.71%
$85.334M
3.751M shares@ $22.76 avg price
TERNTerns Pharmaceuticals Inc
Recent Activity
Decreased -8.58%
1.48%
$46.508M
5.577M shares@ $8.35 avg price
ABVXAbivax Sa
Recent Activity
Decreased -14.36%
1.31%
$41.232M
3.579M shares@ $11.53 avg price
TGTXTg Therapeutics Inc
Recent Activity
Decreased -39.89%
1.28%
$40.348M
1.725M shares@ $23.39 avg price
GERNGeron Corp
Recent Activity
Decreased -41.73%
1.1%
$34.391M
7.575M shares@ $4.54 avg price